Hospital Dipreca

Santiago 7571831

0 studies enrolling now · 2 studies all time

What they study most

Ischemic Stroke; Ischemic Attack, Transient, Secondary Acute Myeloid Leukemia (Secondary AML, sAML)

Studies at this site

• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study — Status unconfirmed